Company profile: Wesana Health
1.1 - Company Overview
Company description
- Provider of advancement of psilocybin-based medicine as a life sciences company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Wesana Health
NKGen Biotech
HQ: United States
Website
- Description: Provider of natural killer (NK) cell therapy candidates to restore immune function for cancer treatment, including SNK01, an autologous NK therapy in clinical trials for neurodegenerative diseases and various cancers, and SNK02, an allogeneic NK therapy being tested for solid tumors, plus an Expanded Access Program enabling access to investigational therapies under specific conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NKGen Biotech company profile →
Blockade Medical
HQ: United States
Website
- Description: Provider of catheter-based therapeutic devices for the treatment of cerebral aneurysms. Founded in 2011, Blockade Medical is a privately held company with a management team totaling 65+ years in the neurovascular field, committed to bringing products to market that are current standards of care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blockade Medical company profile →
Statera Spine
HQ: United States
Website
- Description: Provider of software-enabled spine imaging analytics solutions for chronic and acute spine issues, offering diagnostic and decision-making tools including Profile-ESP for standardized spinal motion and alignment data reports, and VMA, a fluoroscopy imaging system assessing spinal instability and sagittal alignment with measurements for surgical decisions and insurance disputes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Statera Spine company profile →
Athira Pharma
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology and pharmaceutical drug development focused on neurodegenerative diseases. Develops small-molecule therapies including fosgonimeton, which enhances hepatocyte growth factor/MET activity for conditions like Alzheimer’s and Parkinson’s, and ATH-1105, a positive modulator of the neurotrophic HGF system for ALS. Conducts clinical trials to assess safety and efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Athira Pharma company profile →
Vico Therapeutics
HQ: The Netherlands
Website
- Description: Provider of RNA-modulating therapies for rare neurological/CNS disorders, focused on SCA, HD and RTT. Offers VO659, an antisense oligonucleotide targeting CAG repeat expansions in polyglutamine diseases (Spinocerebellar Ataxia types 1/3 and Huntington’s) to reduce mutant protein levels and improve motor function, and VICOMER, a platform designing RNA therapeutics via translation, splicing, editing, degradation and activation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vico Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Wesana Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Wesana Health
2.2 - Growth funds investing in similar companies to Wesana Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Wesana Health
4.2 - Public trading comparable groups for Wesana Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →